Correlation Between Park Electrochemical and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Park Electrochemical and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Park Electrochemical and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Park Electrochemical and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Park Electrochemical and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Park Electrochemical with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Park Electrochemical and Tarsus Pharmaceuticals.
Diversification Opportunities for Park Electrochemical and Tarsus Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Park and Tarsus is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Park Electrochemical and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Park Electrochemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Park Electrochemical are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Park Electrochemical i.e., Park Electrochemical and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Park Electrochemical and Tarsus Pharmaceuticals
Considering the 90-day investment horizon Park Electrochemical is expected to generate 0.56 times more return on investment than Tarsus Pharmaceuticals. However, Park Electrochemical is 1.79 times less risky than Tarsus Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 1,439 in Park Electrochemical on October 28, 2024 and sell it today you would earn a total of 48.00 from holding Park Electrochemical or generate 3.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Park Electrochemical vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Park Electrochemical |
| Tarsus Pharmaceuticals |
Park Electrochemical and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Park Electrochemical and Tarsus Pharmaceuticals
The main advantage of trading using opposite Park Electrochemical and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Park Electrochemical position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Park Electrochemical vs. Innovative Solutions and | Park Electrochemical vs. VSE Corporation | Park Electrochemical vs. Curtiss Wright | Park Electrochemical vs. Ducommun Incorporated |
| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |